Crossmark Global Holdings Inc. Has $264,000 Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Crossmark Global Holdings Inc. reduced its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,656 shares of the company’s stock after selling 421 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Acadia Healthcare were worth $264,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. State Street Corp increased its holdings in Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares in the last quarter. LMR Partners LLP bought a new stake in Acadia Healthcare during the third quarter worth $1,616,000. Principal Financial Group Inc. boosted its position in Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares during the last quarter. Finally, Sivik Global Healthcare LLC boosted its position in Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after purchasing an additional 34,997 shares during the last quarter.

Analyst Ratings Changes

Several research analysts have weighed in on ACHC shares. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $64.00 price target on shares of Acadia Healthcare in a research report on Friday, January 10th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Finally, TD Cowen dropped their price target on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Trading Up 1.1 %

Shares of ACHC opened at $44.68 on Tuesday. The company’s fifty day moving average is $41.30 and its 200 day moving average is $56.16. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The stock has a market capitalization of $4.15 billion, a PE ratio of 14.65, a P/E/G ratio of 1.79 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the business posted $0.91 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.39 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.